Vaccinology During and After COVID-19

COVID-19 期间和之后的疫苗学

• 批准号: 10753782
• 负责人: TERRY L. SHEPPARD
• 金额: $ 0.75万
• 依托单位: KEYSTONE SYMPOSIA
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-07-20 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10753782
• 关键词: 2019-nCoV; Affect; Antibody Response; B-Lymphocytes; COVID-19; COVID-19 impact; COVID-19 pandemic; COVID-19 vaccine; Clinical Medicine; Collaborations; Communicable Diseases; Development; Dimensions; Economics; Educational workshop; Ensure; Equity; Ethics; Future; Human; Immunity; Immunology; Industrialization; Inequality; International; Investments; Knowledge; Learning; Licensing; Medical; Mentors; Methodology; Microbiology; Outcome; Pharmaceutical Preparations; Politics; Privatization; Public Health; RNA vaccine; Recording of previous events; Research; Research Personnel; Science; Scientist; Smallpox; Sociology; Speed; Surveys; Systems Biology; T-Lymphocyte; Technology; Testing; Time; Translations; Vaccination; Vaccines; Virus; clinical implementation; clinical practice; combat; design; future pandemic; global health; improved; innovation; interest; multidisciplinary; new technology; novel therapeutics; pandemic disease; pandemic preparedness; pathogen; post-COVID-19; posters; prospective; structural biology; symposium; vaccine access; vaccine distribution; vaccine platform; vaccinology; virtual

ABSTRACT Support is requested for a Keystone Symposia conference entitled Vaccinology During and After COVID-19, organized by Drs. Bali Pulendran, Robert Seder and Gagandeep Kang. The conference will be held in Atlanta, Georgia from September 17-21, 2023. Since its emergence, SARS-CoV-2 has radically transformed practically every dimension of our lives and fueled an urgent global imperative to develop safe and effective vaccines. The stunning pace at which COVID- 19 vaccines have been developed is unprecedented in the history of vaccinology and has been catalyzed by the rapid harnessing of innovative new technologies (e.g., mRNA vaccines) and major public and private investments. The COVID-19 pandemic offered a unique vantage point from which to survey vaccinology as it was for the past two centuries, since Edward Jenner and the eradication of smallpox, to how it is now, during the time of COVID-19, and to consider what it could be in the post-COVID era. Equally important has been the world’s focus on the economics, politics and ethics of how to ensure global equitable access to COVID-19 vaccines. This virus has certainly shone a spotlight on the field of vaccinology as it is, at the focal point of immunology, microbiology, public health, clinical medicine, economics, sociology, ethics and international diplomacy. Thus, some talks will also be focused on these broader issues surrounding the field. It is anticipated that this conference will stimulate debate that helps enhance pandemic preparedness by redefining the way we conceive of, make, test, license and distribute vaccines globally. Overall, this conference is designed to bring together an interdisciplinary team of experts to discuss the lessons learnt from the COVID-19 pandemic, with a particular focus on the immunology of vaccination.

摘要 请求支持一个名为“2019冠状病毒病期间和之后的疫苗学”的基石研讨会， 由Bali Pulendran、Robert Seder和Gagandeep Kang博士组织。会议将在亚特兰大举行， 格鲁吉亚，2023年9月17日至21日。 自出现以来，SARS-CoV-2几乎从根本上改变了我们生活的方方面面， 全球迫切需要开发安全有效的疫苗。新冠肺炎的惊人速度- 19种疫苗的开发在疫苗学史上是前所未有的， 迅速利用创新的新技术（例如，mRNA疫苗）和主要的公共和私人 投资. 2019冠状病毒病大流行提供了一个独特的Vantage位置，从这个角度来调查疫苗学，因为它 是在过去的两个世纪里，从爱德华詹纳和天花的根除，到现在， COVID-19的时间，并考虑它在后COVID时代可能是什么。同样重要的是， 世界关注如何确保全球公平获得COVID-19的经济，政治和伦理 疫苗。这种病毒无疑是疫苗学领域的焦点， 免疫学、微生物学、公共卫生、临床医学、经济学、社会学、伦理学和国际 外交。因此，一些会谈也将集中在围绕该领域的这些更广泛的问题上。预计 这次会议将激发辩论，通过重新界定我们如何 设想、制造、测试、许可和在全球分发疫苗。总的来说，本次会议旨在 由跨学科专家组成的团队，讨论从COVID-19大流行中汲取的经验教训， 特别关注疫苗接种的免疫学。